Published in Biomed Res Int on January 29, 2014
Effects of Exendin-4 on bone marrow mesenchymal stem cell proliferation, migration and apoptosis in vitro. Sci Rep (2015) 0.90
The Effect of Quercetin on the Osteogenesic Differentiation and Angiogenic Factor Expression of Bone Marrow-Derived Mesenchymal Stem Cells. PLoS One (2015) 0.85
Mesenchymal progenitors in osteopenias of diverse pathologies: differential characteristics in the common shift from osteoblastogenesis to adipogenesis. Sci Rep (2016) 0.79
Combined delivery of PDGF-BB and BMP-6 for enhanced osteoblastic differentiation. J Mater Sci Mater Med (2015) 0.78
In vitro comparison of the efficacy of TGF-β1 and PDGF-BB in combination with freeze-dried bone allografts for induction of osteogenic differentiation in MG-63 osteoblast-like cells. J Mater Sci Mater Med (2016) 0.75
Prevalence and control of diabetes in Chinese adults. JAMA (2013) 11.73
Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis. Osteoporos Int (2006) 5.50
Control of osteoblast function and regulation of bone mass. Nature (2003) 5.06
Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol (2007) 4.11
Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial. J Periodontol (2005) 3.24
MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1. J Biol Chem (2000) 2.83
Critical role of the extracellular signal-regulated kinase-MAPK pathway in osteoblast differentiation and skeletal development. J Cell Biol (2007) 2.44
Osteoporosis in patients with diabetes mellitus. J Bone Miner Res (2007) 2.27
Recombinant human platelet-derived growth factor: biology and clinical applications. J Bone Joint Surg Am (2008) 1.66
Regulation of skeletal development by the Runx family of transcription factors. J Cell Biochem (2005) 1.65
Role of adult mesenchymal stem cells in bone tissue engineering applications: current status and future prospects. Tissue Eng (2005) 1.50
Understanding the pathology and mechanisms of type I diabetic bone loss. J Cell Biochem (2007) 1.48
Transcriptional regulation of osteoblasts. Ann N Y Acad Sci (2007) 1.45
PDGF in bone formation and regeneration: new insights into a novel mechanism involving MSCs. J Orthop Res (2011) 1.36
Mandibular repair in rats with premineralized silk scaffolds and BMP-2-modified bMSCs. Biomaterials (2009) 1.29
Interactions between extracellular signal-regulated kinase 1/2 and p38 MAP kinase pathways in the control of RUNX2 phosphorylation and transcriptional activity. J Bone Miner Res (2012) 1.18
Does diabetes delay fracture healing? Clin Orthop Relat Res (1972) 1.16
Growth factor preconditioning increases the function of diabetes-impaired mesenchymal stem cells. Stem Cells Dev (2010) 1.14
Type 1 diabetes in young rats leads to progressive trabecular bone loss, cessation of cortical bone growth, and diminished whole bone strength and fatigue life. J Bone Miner Res (2009) 1.14
Accelerated fracture healing in the geriatric, osteoporotic rat with recombinant human platelet-derived growth factor-BB and an injectable beta-tricalcium phosphate/collagen matrix. J Orthop Res (2008) 1.10
The effect of diabetes mellitus on osseous healing. Clin Oral Implants Res (2010) 1.09
Persistent high glucose concentrations alter the regenerative potential of mesenchymal stem cells. Stem Cells Dev (2010) 1.06
Concise review: Insights from normal bone remodeling and stem cell-based therapies for bone repair. Stem Cells (2010) 1.05
Diabetes induced changes in rat mesenchymal stem cells. Cells Tissues Organs (2010) 1.05
Differential regulation of platelet-derived growth factor stimulated migration and proliferation in osteoblastic cells. J Cell Biochem (2004) 1.04
Akt- and Erk-mediated regulation of proliferation and differentiation during PDGFRβ-induced MSC self-renewal. J Cell Mol Med (2012) 1.00
Recombinant human platelet-derived growth factor BB (rhPDGF-BB) and beta-tricalcium phosphate/collagen matrix enhance fracture healing in a diabetic rat model. J Orthop Res (2009) 1.00
Effect of diabetes and metabolic control on de novo bone formation following guided bone regeneration. Clin Oral Implants Res (2009) 0.98
Molecular basis for affected cartilage formation and bone union in fracture healing of the streptozotocin-induced diabetic rat. Bone (2008) 0.98
Decreased platelet derived growth factor expression during fracture healing in diabetic animals. Clin Orthop Relat Res (2003) 0.97
The healing of critical-size calvarial bone defects in rat with rhPDGF-BB, BMSCs, and β-TCP scaffolds. J Mater Sci Mater Med (2012) 0.92
Mesenchymal stem cells accelerate bone allograft incorporation in the presence of diabetes mellitus. J Orthop Res (2010) 0.91
Diabetes and skeletal health. J Diabetes (2009) 0.91
Diabetes mellitus and healing of closed fractures. Diabete Metab (1992) 0.84
Regulation of human bone sialoprotein gene transcription by platelet-derived growth factor-BB. Gene (2009) 0.84
Osteogenic potential of bone marrow stromal cells derived from streptozotocin-induced diabetic rats. Int J Mol Med (2013) 0.83
Platelet-derived growth factor stimulates osteoprotegerin production in osteoblastic cells. J Cell Physiol (2009) 0.82
Bone marrow cells from normal and ovariectomized rats respond differently to basic fibroblast growth factor and bone morphogenetic protein 2 treatment in vitro. Tissue Eng (2005) 0.81
BMP-2 gene modified canine bMSCs promote ectopic bone formation mediated by a nonviral PEI derivative. Ann Biomed Eng (2011) 0.78